1 eagent, N-[(2-pyridyldithio)-ethyl], 4-azido salicylamide.

2 an N-Mannich linkage between doxorubicin and salicylamide.

3 ldehyde conjugate via an N-Mannich base of a salicylamide derivative.

4                                          The salicylamide-grafted PEI showed to be a reliable carrier

5 nd between that OH and the carbonyl O of the salicylamide linkage are important.

6 sted that the phenolic hydroxyl group in the salicylamide ring was required for activity, while the t

7                                              Salicylamide (SAL), an analgesic drug, caused a potent a

8 roup that spanned from the 5-position of the salicylamide to the 3'-position of cyanonilutamide.

9                                          The salicylamide triggering molecule, previously developed t

10                                          The salicylamide was selected to serve as a trigger release

11                      A series of azole-fused salicylamides were prepared as analogues of antimycin an